New products
First patient treated in Spiro’s PULSAR asthma trial
Spiro Medical has enrolled the first patient in its PULSAR feasibility study, which evaluates a neuromodulation device for treating severe, uncontrolled asthma. The trial marks an early-stage clinical evaluation of the company's therapeutic approach to a patient population with limited options.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network